We make this in a patent-pending base that helps absorb the larger semaglutide molecule As of April 22, 2025, the compounded injectable semaglutide will no longer be available due to the FDAs declaration of drug shortages being removed
Some people may notice mild effects such as bloating, cramps, or loose stools, usually temporary
This selective uptake means that most hydrophilic molecules cannot enter cells, since they are not recognised by any specific transporters
Upstream processing Solid-phase peptide synthesis (SPPS) The GLP-1 manufacturing process starts with peptide synthesis, during which amino acids are attached one at a time to form a peptide chain
As of September 2023 it is on the FDA Category 2 list of bulk drug substances that may not be compounded, and a PCAC review is scheduled for July 2026 under the name Emideltide